| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.068 | 0.2 |